Cardiology (all articles)
Cohort Study | Androgen-deprivation therapy and risk of death from cardio-vascular disease in prostate cancer patients.
28 Jul, 2022 | 13:13h | UTCNews Release: Hormone therapy for prostate cancer increases the risk of dying from cardiovascular disease – Taylor & Francis
Cohort Study | Predictive utility of a validated polygenic risk score for long-term risk of coronary heart disease in young and middle-aged adults.
28 Jul, 2022 | 13:15h | UTCPredictive Utility of a Validated Polygenic Risk Score for Long-Term Risk of Coronary Heart Disease in Young and Middle-Aged Adults – Circulation (free for a limited period)
News Release: Old-School Health Assessment Beats Genetic Test for Predicting Heart Disease – Nuke University
USPSTF Recommendations | Behavioral counseling interventions to promote a healthy diet and physical activity in adults without cardiovascular disease risk factors.
27 Jul, 2022 | 12:26h | UTCEditorials:
Improving Behavioral Counseling for Primary Cardiovascular Disease Prevention – JAMA Cardiology
Author Interview: USPSTF Recommendation: Behavioral Counseling Interventions to Promote Healthy Behaviors for CVD Prevention – JAMA
RCT | Effect of high- vs. low-dose tranexamic acid infusion on need for red blood cell transfusion and adverse events in patients undergoing cardiac surgery.
27 Jul, 2022 | 12:21h | UTCEffect of High- vs Low-Dose Tranexamic Acid Infusion on Need for Red Blood Cell Transfusion and Adverse Events in Patients Undergoing Cardiac Surgery: The OPTIMAL Randomized Clinical Trial – JAMA (free for a limited period)
Commentary on Twitter
#OrigInvestigation: Among pts who underwent cardiac surgery w cardiopulmonary bypass, high-dose vs low-dose tranexamic acid infusion resulted in a modest, statistically significant reduction in the proportion of pts receiving allogeneic RBC transfusion https://t.co/Eb7SWc8U26
— JAMA (@JAMA_current) July 26, 2022
Practical Guide | Antihypertensive deprescribing in older adults.
27 Jul, 2022 | 12:23h | UTCAntihypertensive Deprescribing in Older Adults: a Practical Guide – Current Hypertension Reports
Cohort Study | Long-term risk of cardiovascular disease mortality among classic Hodgkin lymphoma survivors.
27 Jul, 2022 | 11:53h | UTCLong-term risk of cardiovascular disease mortality among classic Hodgkin lymphoma survivors – Cancer
Commentaries:
CVD Mortality Leading Cause of Death for Stage I, II Hodgkin Lymphoma – HealthDay
20-year follow-up of a RCT trial | Immunosuppressive therapy in virus-negative inflammatory cardiomyopathy.
26 Jul, 2022 | 13:33h | UTCCommentary: Immunosuppression may benefit long term in virus-negative inflammatory cardiomyopathy – Healio (free registration required)
Commentary on Twitter
Immunosuppressive therapy in virus-negative inflammatory cardiomyopathy: 20-year follow-up of the TIMIC trial@escardio @ESC_Journals #CardioTwitter #EHJhttps://t.co/XpZj0UrJo5 pic.twitter.com/PIq0Bzwhpu
— EHJ Editor-in-Chief (@ehj_ed) July 19, 2022
Under a https://creativecommons.org/licenses/by/4.0/ license
Cohort Study | Cardiometabolic outcomes up to 12 months after COVID-19 infection.
26 Jul, 2022 | 13:30h | UTCNews Release: COVID-19 patients more likely to develop cardiovascular diseases and diabetes soon after infection – PLOS
Commentaries:
COVID-19 tied to new-onset, short-term heart disease, diabetes – CIDRAP
CVD, Diabetes Spike in Acute Phase of COVID-19 – TCTMD
M-A | Effectiveness of wearable activity trackers to increase physical activity and improve health.
26 Jul, 2022 | 13:27h | UTC
Commentary on Twitter
Effectiveness of wearable activity trackers to increase physical activity and improve health: a systematic review of systematic reviews and meta-analyses https://t.co/JecWHjcnpg pic.twitter.com/MPnQHU1VQQ
— Søren T. Skou (@STSkou) July 21, 2022
Under a CC BY-NC-ND 4.0 license
Systematic Review | Antiplatelet agents for the treatment of deep venous thrombosis.
26 Jul, 2022 | 12:44h | UTCAntiplatelet agents for the treatment of deep venous thrombosis – Cochrane Library
Summary: Aspirin and similar drugs for the treatment of deep vein thrombosis (DVT) – Cochrane Library
Non-alcoholic fatty liver disease and risk of new-onset heart failure: an updated meta-analysis of about 11 million individuals.
26 Jul, 2022 | 12:36h | UTCNews Release: Fat build-up in liver (NAFLD) linked to heightened heart failure risk over next decade – BMJ
Commentary: NAFLD Tied to Higher Risk of Heart Failure — Meta-analysis showed a modest risk independent of key risk factors – MedPage Today (free registration required)
Cohort Study | Polygenic risk, midlife life’s simple 7, and lifetime risk of stroke.
26 Jul, 2022 | 12:38h | UTCNews Release: A healthy lifestyle can offset a high genetic risk for stroke – University of Texas Health Science Center at Houston
Commentary: Lifetime Risk for Stroke Varies With Genetic Risk, Cardiovascular Health – HealthDay
Cohort Study | Incidence, associated risk factors, and outcomes of postoperative arrhythmia after upper gastrointestinal surgery.
26 Jul, 2022 | 11:52h | UTCCommentary: Incidence and Outcomes of Postop Arrhythmia After Upper GI Surgery – American College of Cardiology
Commentary on Twitter
This cohort study of 1,210 patients undergoing upper GI surgery found new-onset postop atrial fibrillation (AF) was associated with increased in-hospital mortality, prolonged ICU stay, and development of permanent or paroxysmal AF. https://t.co/8Bxq5uGuqa
— JAMA Network Open (@JAMANetworkOpen) July 21, 2022
M-A | Mortality and clinical predictors after percutaneous mitral valve repair for secondary mitral regurgitation.
26 Jul, 2022 | 11:49h | UTC
Cohort Study | Markers of focal and diffuse nonischemic myocardial fibrosis are associated with adverse cardiac remodeling and prognosis in patients with hypertension.
26 Jul, 2022 | 11:46h | UTCCommentary: Heart muscle scarring found in patients with hypertension are associated with worse outcomes – SingHealth
RCT | External support for saphenous vein grafts in coronary artery bypass surgery.
26 Jul, 2022 | 11:44h | UTCExternal Support for Saphenous Vein Grafts in Coronary Artery Bypass Surgery: A Randomized Clinical Trial – JAMA Cardiology (link to abstract – $ for full-text)
Commentary on Twitter
This RCT found that the 12-month difference in intimal hyperplasia area between supported and unsupported grafts did not achieve statistical significance, after accounting for early graft occlusions. https://t.co/Qrx3QsmdLc
— JAMA Cardiology (@JAMACardio) July 4, 2022
Brief Review | Contraception in women with cardiovascular disease.
25 Jul, 2022 | 13:05h | UTCContraception in Women With Cardiovascular Disease – JAMA (free for a limited period)
SCMR Consensus Statement | Cardiovascular magnetic resonance of acquired and non-structural pediatric heart disease.
22 Jul, 2022 | 11:43h | UTC
Chasing LDL cholesterol to the bottom — PCSK9 in perspective.
22 Jul, 2022 | 11:36h | UTCChasing LDL cholesterol to the bottom — PCSK9 in perspective – Nature Cardiovascular Research (if the link is paywalled, try this one)
Commentary on Twitter
Review| @LaleTokgozoglu and Peter Libby discuss the management of #atherogenic #LDL cholesterol with an emphasis on the role #PCSK9 inhibition strategies https://t.co/k1wPKAdotU
— Nature Cardiovascular Research (@NatureCVR) June 17, 2022
Development and validation of a decision support tool for the diagnosis of acute heart failure: systematic review, meta-analysis, and modelling study.
22 Jul, 2022 | 11:18h | UTC
Commentary from the author on Twitter
In an international collaborative analysis, we developed a decision-support tool (CoDE-HF) that rules-in and rules-out acute heart failure more accurately than any approach using NT-proBNP thresholds alone- published today @bmj_latest https://t.co/JtPBEzcGqu pic.twitter.com/bCo9Xlzt5b
— Ken Lee (@KuanKenLee) June 13, 2022
Under a http://creativecommons.org/licenses/by/4.0/ license
RCT | In patients undergoing cardiac surgery with cardiopulmonary bypass, using a 4% albumin solution for volume expansion did not reduce adverse events compared to ringer acetate.
21 Jul, 2022 | 13:32h | UTCEffect of 4% Albumin Solution vs Ringer Acetate on Major Adverse Events in Patients Undergoing Cardiac Surgery With Cardiopulmonary Bypass: A Randomized Clinical Trial – JAMA (free for a limited period)
Editorial: Albumin vs Crystalloid Fluid for Resuscitation in Cardiac Surgery: New Evidence and Arguments in the Timeless Debate – JAMA (free for a limited period)
Commentary: Trial does not support albumin as primer, volume replacement solution in CABG – Healio (free registration required)
Commentary on Twitter
#OriginalInvestigation: Clinical trial findings do not support the use of 4% albumin solution in cardiac surgery with cardiopulmonary bypass. @EeroJPesonen https://t.co/uyWQRdxfuJ pic.twitter.com/RJ5M9NBb9x
— JAMA (@JAMA_current) July 19, 2022
Retrospective Cohort Study | Major adverse cardiovascular events in patients with renal cell carcinoma treated with targeted therapies.
21 Jul, 2022 | 12:54h | UTC
Open-label RCT | Moderate-intensity statin plus ezetimibe is noninferior to high-intensity statin monotherapy in patients with atherosclerotic cardiovascular disease.
20 Jul, 2022 | 12:32h | UTCLong-term efficacy and safety of moderate-intensity statin with ezetimibe combination therapy versus high-intensity statin monotherapy in patients with atherosclerotic cardiovascular disease (RACING): a randomised, open-label, non-inferiority trial – The Lancet (link to abstract – $ for full-text)
AHA Scientific Statement | Polygenic risk scores for cardiovascular disease.
20 Jul, 2022 | 12:31h | UTC
High-sensitivity cardiac troponin and the 2021 AHA/ACC Guidelines for the evaluation and diagnosis of acute chest pain.
20 Jul, 2022 | 12:29h | UTCHigh-Sensitivity Cardiac Troponin and the 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guidelines for the Evaluation and Diagnosis of Acute Chest Pain – Circulation (free for a limited period)
Commentary on Twitter
#Primer HS Cardiac Troponin & Guidelines for Evaluation and Diagnosis of Acute Check Pain #AHAJournals https://t.co/avcm6LEbgb pic.twitter.com/zs8yRe6u1y
— Circulation (@CircAHA) July 13, 2022